Literature DB >> 19940458

Donors perceptions of consent to and feedback from biobank research: time to acknowledge diversity?

K Hoeyer1.   

Abstract

BACKGROUND: Many studies have explored public perspectives on when and how to provide informed consent to biobank research and when to get feedback on research results. Little has been done to explore overarching trends in these studies.
METHODS: The article is based on a critical reading of the literature found through Medline searches and the PRIVILEGED project compilation of empirical studies.
RESULTS: I suggest that tissue type, procurement situation including who is asked to provide consent, and the biobank's geographical, social and historical context influence how various potential donors view the issues of consent, re-consent, and feedback of research results. In light of this, universal ethical standards for informed consent to and feedback of research results from biobank research seem to run contrary to the diversity of perceptions and expectations among different donors.
CONCLUSION: To respect donor interests, it is necessary to pay more attention to diversity with regard to biobank types and different contexts for donation. We should avoid assuming that words like 'biobank' and 'donor' can be used in a generic sense - always referring to the same - if we wish to respect and care for the diverse group of individuals who comprise the donating public.

Entities:  

Mesh:

Year:  2009        PMID: 19940458     DOI: 10.1159/000262329

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  34 in total

1.  The meaning of genetic research results: reflections from individuals with and without a known genetic disorder.

Authors:  R Jean Cadigan; Marsha Michie; Gail Henderson; Arlene M Davis; Laura M Beskow
Journal:  J Empir Res Hum Res Ethics       Date:  2011-12       Impact factor: 1.742

2.  Biobank governance: heterogeneous modes of ordering and democratization.

Authors:  Herbert Gottweis; Georg Lauss
Journal:  J Community Genet       Date:  2011-12-07

3.  Connecting the public with biobank research: reciprocity matters.

Authors:  Herbert Gottweis; George Gaskell; Johannes Starkbaum
Journal:  Nat Rev Genet       Date:  2011-10-18       Impact factor: 53.242

4.  Factors influencing public participation in biobanking.

Authors:  Mamoun Ahram; Areej Othman; Manal Shahrouri; Ebtihal Mustafa
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

5.  Public support and consent preference for biomedical research and biobanking in Jordan.

Authors:  Mamoun Ahram; Areej Othman; Manal Shahrouri
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

6.  Withdrawal from biobank research: considerations and the way forward.

Authors:  Kristina Hug; Göran Hermerén; Mats Johansson
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

7.  Online Education and e-Consent for GeneScreen, a Preventive Genomic Screening Study.

Authors:  R Jean Cadigan; Rita Butterfield; Christine Rini; Margaret Waltz; Kristine J Kuczynski; Kristin Muessig; Katrina A B Goddard; Gail E Henderson
Journal:  Public Health Genomics       Date:  2017-10-26       Impact factor: 2.000

8.  A trade secret model for genomic biobanking.

Authors:  John M Conley; Robert Mitchell; R Jean Cadigan; Arlene M Davis; Allison W Dobson; Ryan Q Gladden
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

9.  'Mirroring' the ethics of biobanking: what should we learn from the analysis of consent documents[corrected]?

Authors:  Jurate Serepkaite; Serepkaite Jurate; Zivile Valuckiene; Valuckiene Zivile; Eugenijus Gefenas; Gefenas Eugenijus
Journal:  Sci Eng Ethics       Date:  2013-10-18       Impact factor: 3.525

10.  Active choice but not too active: public perspectives on biobank consent models.

Authors:  Christian M Simon; Jamie L'heureux; Jeffrey C Murray; Patricia Winokur; George Weiner; Elizabeth Newbury; Laura Shinkunas; Bridget Zimmerman
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.